Immune-Onc Therapeutics
Stuart Lutzker is a Scientific Advisor at Immune-Onc Therapeutics. Stuart was previously a Vice President at Genentech, Arrivent Biopharma, and Immune-Onc Therapeutics. Stuart has been working in the field of oncology for over 17 years. Stuart received their BA from the University of California, Berkeley and their PhD from Stanford University.
Stuart Lutzker's educational career includes a MD-PhD from Columbia University Vagelos College of Physicians and Surgeons as well as a Bachelor of Arts (BA) from Columbia University in the City of New York.
This person is not in the org chart
This person is not in any offices
Immune-Onc Therapeutics
Immune-Onc Therapeutics, Inc. (“Immune-Onc”) is a clinical-stage cancer immunotherapy company dedicated to the discovery and development of novel myeloid checkpoint inhibitors for cancer patients. Headquartered in Palo Alto, California, Immune-Onc has assembled a diverse team with deep expertise in drug development and proven track records of success at leading biotechnology companies.